This document discusses various methods for measuring disease frequency and trends. It defines key epidemiological terms like prevalence, incidence, odds ratio, and relative risk. It explains how to calculate these measures and interpret them. For example, it shows how to calculate the odds ratio from a 2x2 table to measure the association between alcohol use and accidents. It also discusses factors that can indicate a causal relationship and gives examples of time series analysis of disease trends over time.
A principal aim of epidemiology is to assess the cause of disease. However, since most epidemiological studies are by nature observational rather than experimental, a number of possible explanations for an observed association need to be considered before we can infer a cause-effect relationship exists.
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
An overview of a key statistical technique in epidemiology – standardization - is introduced. The process and application of both direct and indirect standardization in improving the validity of comparisons between populations are described.
A principal aim of epidemiology is to assess the cause of disease. However, since most epidemiological studies are by nature observational rather than experimental, a number of possible explanations for an observed association need to be considered before we can infer a cause-effect relationship exists.
This PPT discusses
Basics measurements in epidemiology
Basics requirements of measurements
Tools of measurements
Measures of morbidity
Measures of disability
Measures of mortality
An overview of a key statistical technique in epidemiology – standardization - is introduced. The process and application of both direct and indirect standardization in improving the validity of comparisons between populations are described.
The STUDY of the DISTRIBUTION and DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems."
It gives all the important definitions used in infectious disease epidemiology and continues to elaborate on dynamics of disease transmission followed by prevention and control of infectious diseases.
Standardization of rates by Dr. Basil TumainiBasil Tumaini
Standardization of rates by Dr. Basil Tumaini, presented during the residency at Muhimbili University of Health and Allied Sciences, Epidemiology class
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
Study design, Epidemiological study designA study design is a specific plan or protocol
for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.
Introduction to Epidemiology
History of Epidemiology.
Definition of Epidemiology and its components.
Epidemiological Basic concepts.
Aims of Epidemiology.
Ten Uses of Epidemiology.
Scope or The Areas of Application .
Types of Epidemiological Studies.
The STUDY of the DISTRIBUTION and DETERMINANTS of HEALTH-RELATED STATES in specified POPULATIONS, and the application of this study to CONTROL of health problems."
It gives all the important definitions used in infectious disease epidemiology and continues to elaborate on dynamics of disease transmission followed by prevention and control of infectious diseases.
Standardization of rates by Dr. Basil TumainiBasil Tumaini
Standardization of rates by Dr. Basil Tumaini, presented during the residency at Muhimbili University of Health and Allied Sciences, Epidemiology class
Study designs, Epidemiological study design, Types of studiesDr Lipilekha Patnaik
Study design, Epidemiological study designA study design is a specific plan or protocol
for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one.
Introduction to Epidemiology
History of Epidemiology.
Definition of Epidemiology and its components.
Epidemiological Basic concepts.
Aims of Epidemiology.
Ten Uses of Epidemiology.
Scope or The Areas of Application .
Types of Epidemiological Studies.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Measurement of Disease
for Outbreaks and Trends
• Measurement of disease burden
• Prevalence, Proportion, % etc
• Measurement of disease occurrence
• Incidence, death rate,
• Measurement of association (risk vs outcome)
• Odds Ratio, RR
• Measurement of Trends and Distributions**
• Dose – response, Trends over time cohort (APC)
• Time Series etc.
3. Measurement of disease burden
• Count (number) and unit of count (such as
aggregate number – group, cluster, flock etc)
• Count and proportion (number of case per
survey population, %, ratio – m:f)
• Prevalence (magnitude)
4. Prevalence
Prevalence =
Number of existing cases at a point of time
Average size of the population at the period of time
Prevalence =
No. of existing cases + new cases during a period of time
Size of the population at a point of time
(point)
period
5. Prevalence (point)
Prevalence =
Number of DM cases in the survey of a village
Size of the population of the village
(point)
=
36
3200 villager
= 0.01125 Or 1.12 person in 100 people
6. Prevalence
Average size of the population at the period of time
Prevalence =
No. of existing cases + new cases during a period of time
period
=
36 + 12 In 6 months period
3200 villager + 200 (birth and move in, minus died)
= 48
3400
= 0.0141 Or 1.4 in 100 villager
7. Measurement of disease occurrence
Incidence (rate) =
No. of FMD in cows in 1 year
Size of population at risk who stay in the area in 1 year
=
New cases occur in an observed period ( 1 year)
Population of cows in the province in 1 year
=
500
2500
= 200 FMD per 1000 Cows per year
X 1000 or 100000
X 10000
Incidence is rate of change : unit of calculation is per time (t minus 1)
(incidence rate, death rate etc.
8. Common measurement in descriptive epidemiology
• Count
• Ratio (A:B) such as M:F
• Proportion (of Total, of school attendant)
• Percentage %
• Prevalence
• Rate (of change) – incidence
• Case Fatality Rate : CFR) - proportion
• Summary of data variable (Mean, Median, Mode)
9. Number of patients with “D” disease reported from
all hospitals in Province/Division ‘M’ by week, in 201X
Hospital
Area Total 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Provineial H 1778 112 112 101 101 112 116 100 101 127 123 89 85 87 103 63 86 75 68 7
Hosp A 163 28 31 26 28 13 12 9 5 11
Hosp B 5 1 1 1 1 1
Hosp C 169 24 16 14 22 25 23 20 4 1 2 16
Hosp D 656 44 37 48 44 27 21 43 24 24 19 14 39 28 43 41 45 34 39 28
Hosp E 466 19 33 36 38 28 20 40 23 16 21 27 16 21 21 14 27 18 24 22
Hosp F 226 17 17 26 23 47 26 41 22 2
Hosp G 242 27 18 25 33 21 20 33 18 28 17 1
10. Understand sources of data
and how data collected
• Definition of case required for notification
• Surveillance and reporting system (and
requirement – such as priority/urgent etc)
• Reporting Persons, organization
• Timeliness
• Completion
• Evaluation and supervision
• Technology
11. Previous slide content show
• Count per week
• Count of cases among different hospital/area
• No report and missing data
• Incomplete information in some data
• No information, no data – difficult to analyze or
interpretation
• No population in each area make it hard to
compare the problem
• Can we say something about the trends of
disease?
12. John Snow : Observation and study of
Cholera Outbreak, London 1854
13. Cholera cases, rate per HH
By water supplied company, London 1854.
Southwark & Vauxhall 40,046 1,263 315
Company
Lamberth Company 26,107 98 37
Rest of London 256,423 1,422 59
Tap water
Supplied company
No. HH cases
Case per
10000 HH
15. Index – first case identified
Primary – case that brings the infection into a population
Secondary – infected by a primary case
Tertiary – infected by a secondary case
P
S
S
T
Susceptible
Immune
Asymptomatic
Clinical
S
T
การถ่ายทอดโรค (Disease Transmission)
16. Transmission: Reproductive Number
Basic Reproductive Number (R zero)
Secondary cases occurred as a result of
exposure (contact) to indexed cases or
previous case
Ro = between 1-2 from this example
17. After an ILI index case ill in families
no. of new cases sick in 1 incubation period
Size of families New case occur Index to new case ratio
5 2 1:2
4 2 1:2
3 1 1:1
6 3 1:3
21. Measurement of association (risk vs outcome)
Odds Ratio, RR
Terminology
• Variable (things with information of interest : Sex,
age, Blood sugar, Infection (Y/N), eat food A, bite by
rabid dog, vaccination) (y/n)……etc)
• Association ( possible relationship of x and y)
• Correlation (how x and y go together) (+/-)
• Some association can be cause-effect
relationship
22. Measurement of association (risk vs outcome)
Odds Ratio, RR
Association
• What is Odd and Odds Ration
a:b is Odd of X ( c:d is another odd of Y)
X:Y is Odds Ratio
• What is Relative Risk (similar concept
“Studies showed “Drink alcohol” associated with increase in road accident by 3 times”
23. Calculation format Odd, Odds Ratio
Accident No accident
Drinking “alcohol”
Over 75 mg%
a b a+b
No alcohol c d c+d
a+c b+d N = a+b+c+d
24. Accident No accident
Drinking “alcohol”
Over 75 mg%
a b a+b
No alcohol c d c+d
a+c b+d N =
a+b+c+d
Odd of accident in drinking = a/b
Odd of accident in No drinking = c/d
Odd Ratio of Alcohol in accident = (a/b) /(c/d) = a*d /b*c
ORs = number
+ Calculate 95% Confident Intervals
25. Accident No accident
Drinking “alcohol”
Over 75 mg%
50 500 550
No alcohol 5 1200 1205
55 1700 1755
Odd of accident in drinking = a/b = 50/500 = 0.1
Odd of accident in No drinking = c/d = 5/1200 = 0.00416
Odd Ratio of Alcohol in accident = (0.1) /(0.00416) = 24.04 times
ORs = number
+ Calculate 95% Confident Intervals
26. Calculation format RR, RRs Ratio
Case Measles Normal (child) no
illness
MMR vaccination
a b a+b
No MMR
vaccination
c d c+d
a+c b+d N = a+b+c+d
27. Case Measles Normal (child) no
illness
MMR vaccination a b a+b
No MMR
vaccination
c d c+d
a+c b+d N = a+b+c+d
RR of disease in vaccination = a/a+b
RR of disease in non-vaccination = c/c+d
RRs Ratio is = a(a+b)/(c /(c+d))
28. Case Measles Normal (child) no
illness
MMR vaccination 5 400 405
No MMR
vaccination
28 300 328
33 730 763
RR of disease in vaccination = a/a+b = 5/405 = 0.012
RR of disease in non-vaccination = c/c+d = 28/328 = 0.0853
RRs Ratio is = a(a+b)/(c /(c+d))
= 0.012/0.0853 = 0.14
MMR vaccination has 7.1 time protective effect or approximately 76 % efficacy
29. Cause-effect Association
• Strength of association (high RRs, Ors)
• Consistency
• Specificity
• Temporal relation (A happened before disease)
• Biological Plausibility
• Dose-response relationship
• Coherence
• Experiment support
• Analogy **
** too weak , may not be necessary
34. Main composition of determinants
of a Time Series
• Trend: linear, curvinear, moving average
• Oscillation (cosine function)
– Harmonic terms e.g. cos(a), cos(2a)
– Starting points e.g. cos(m+a), cos(n+2a)
• Autoregressive effect
– Preceding status has effects on the current one.
• Optionally other explanatory independent terms e.g.
temperature, rainfalls, which are beyond the trend
and cyclical effects
• Random errors
35. Temperature, NE Thailand
1975 1980 1985 1990 1995 2000 2005 2010
20
22
24
26
28
30
C
Analysis : Output from R program - red line show
trend of temperature with seasonal (time) variation
39. Age-Period-Cohort (APC)
• Age – risk of disease depend on age such as
– Low immunity in children
– Exposure to chemical, hormone change
– Age related disease, elderly less immunity etc
• Period : certain period living aspect change (60s,
80s, 90s, 2000s, 2010….)
• Cohort : Birth cohort experienced different
era/period
• Interaction for risk factors
40. Hutcha Sriplung Thai Network of Cancer Registries 40
Female breast cancer in Thailand
Year
1989199019911992199319941995199619971998199920002001200220032004200520062007
0
5
10
15
20
25
30
Breast Cancer
Thailand, 1989-2007
Chiang Mai
Lampang
Khon Kaen
Songkhla
Year
ASR(per100000population
41. Hutcha Sriplung Thai Network of Cancer Registries 41
Male colo-rectal cancer in Thailand
89 90 91 92 93 94 95 96 97 98 99 00
0
5
10
15
20
25
Chiang Mai
Lampang
Khon Kaen
Songkhla
Year
ASR /100,000 population
42. Hutcha Sriplung Thai Network of Cancer Registries 42
Tobacco consumption and lung cancer
in Australia
1945
1947
1949
1951
1953
1955
1957
1959
1961
1963
1965
1967
1969
1971
1973
1975
1977
1979
1981
1983
1985
1987
1989
1991
1993
1995
1997
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
Lung Cancer-Male
Lung Cancer-Female
Tobacco consumption
3.0
1.5
0.0
2.0
1.0
2.5
Tobacco
Kg/capita
Death/100,000
population
Year
AIHW: deloop M & Bhatia K 2001: Australian Health Trends 2001. AIHW Cat. No. PHE 24. Canberra: AIHW; the National Mortality
Database.
~20 years